Overall, the results of the present study suggest that plasma p-tau181 is more suitable than NfL and GFAP in the differential diagnosis of AD from disorders belonging to the FTLD spectrum and DLB, irrespective of the disease severity. The gene discussed is NEFL; the disease is Lewy body dementia.